Washington University in St. Louis
Mission Statement
At a Glance
2
Educational Resources Posted
75
Consortium News Stories Posted
3
Events Posted
0
Opportunities Posted
85
Publications citing CTSA Program Grant
36
Users from Hub Registered
UL1 Award
KL2 Award
TL1 Award
UL1
UL1 Director
UL1 Administrator
Education
KL2 Administrator
TL1 Director
TL1 Administrator
Communications
Communications Representative
Enterprise Committees
Integration Across Lifespan Voting Member
Common Metrics
Primary CM Contact
Additional CM Contacts
KatieKeenoyProgram Director, mHRC and Clinical Research Specialist for the Center for Clinical Studies Trial-CARE Unit
PhilipPayneRobert J. Terry Professor and Director, Institute for Informatics (I2)
PhilipPayneAssociate Dean for Health information and Data Science / Chief Data Scientist, Washington University School of Medicine
SusanStarkAssociate Professor of Occupational Therapy, Neurology and Social Work
SureshVedanthamAssistant Dean for Clinical Research, Professor of Radiology & Surgery
Consortium News
The ICTS has awarded four separate awards to investigators in the ICTS’ first-ever virtual poster display and contest. As part of the 4th annual ICTS Symposium, 47 separate posters were submitted and reviewed by 22 ICTS faculty from Washington University in St. Louis, University of Missouri – Columbia, and Saint Louis University. Posters showcased ICTS-supported research and were categorized by
The Washington University Institute of Clinical and Translational Sciences (ICTS) hosted their 4th annual Symposium and Poster Display on Friday, May 13, 2022. The theme “Making an Impact, Shaping the Future” focused on strategies to address equity and diversity challenges experienced by institutions across the national Clinical and Translational Science Awards (CTSA) network. The hybrid event
Washington University School of Medicine in St. Louis has received a $61 million grant from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) to support the infrastructure for developing and carrying out biomedical research studies. The funding supports Washington University’s Institute of Clinical and Translational Sciences (ICTS), which was
Educational Content
Washington University in St. Louis is recruiting for the fall program of our NIH-funded Entrepreneurship for Biomedicine (E4B) training program. E4B is free and taught fully online through Washington University in St. Louis. As an E4B trainee, you will work with biomedical research trainees from across the nation to innovatively solve problems in these challenging times, and develop skills in
Events
“Making an Impact, Shaping the Future” Please join us for the 4th annual symposium hosted by the Washington University Institute of Clinical and Translational Sciences. This year’s theme focuses on strategies to address equity and diversity challenges experienced by institutions across the national CTSA network. This is a hybrid event with opportunities to attend virtually or in-person. May 13
The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
Poster Sessions
Introduction: The STOP COVID Trials were innovative fully-remote randomized controlled trials of fluvoxamine (a sigma1 receptor agonist with anti-inflammatory properties) vs placebo for treatment of outpatients with early COVID-19 who were self-isolating at home. Methods: The trials used eConsent and an electronic data capture system with integrated recruitment from the EPIC electronic health
As a result of the CTSA Program’s objective to strengthen multidisciplinary research infrastructure, hubs are uniquely poised to mobilize their vast resources to produce a rapid, nimble, multi-faceted approach to national public health emergencies. The Institute of Clinical and Translational Sciences, the CTSA grantee at Washington University in St. Louis, is a critical contributor to the
The goal of the Precision Medicine function of the Washington University Institute of Clinical and Translational Sciences is to streamline precision medicine research processes across the university. Three separate initiatives supported this effort: (1) outreach to community and faculty members through surveys and focus groups to assess interest and concerns regarding participation in precision
Publications
Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted therapies, no such targeted therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to prevent sensing of
The safety of hepatectomy after transarterial radioembolization: Single institution experience and review of the literature
The liver is a frequent site of malignancy, both primary and metastatic. The treatment goal of patients with liver cancer may include transarterial radioembolization (TARE). There are limited reports on the safety of hepatectomy following TARE. Our study's purpose is to review patients who have
Eating disorder symptomatology, clinical impairment, and comorbid psychopathology in racially and ethnically diverse college women with eating disorders
To examine eating disorder (ED) symptomatology, related clinical impairment, and comorbid psychopathology in college women with EDs across five racial and two ethnic groups. Participants were 690 women from 28 US universities who screened positive for an ED. Thirteen variables assessing ED symptoms
Research and Operational Tools
The Translational Science Benefits Model (TSBM) is a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures.